Peoria IL 前列腺癌临床试验
9项针对 前列腺癌的研究正在 Peoria及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- 以及另外 1 项
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Illinois Cancer Care ( Site 0104), Peoria
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- OSF Saint Francis Medical Center, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- 以及另外 1 项
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- 以及另外 1 项
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
招募中4 期
- Methodist Medical Center of Illinois, Peoria
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- OSF Saint Francis Medical Center, Peoria
- 以及另外 2 项
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA59 项研究
- St. Louis, MO46 项研究
- Chicago, IL45 项研究
- San Francisco, CA45 项研究
- Philadelphia, PA44 项研究
- Baltimore, MD43 项研究
- Nashville, TN42 项研究
- Seattle, WA42 项研究
- Washington, DC38 项研究
Peoria的其他研究
- 非小细胞肺癌21 项研究
- 肺癌12 项研究
- 结直肠癌12 项研究
- 心力衰竭8 项研究
- 乳腺癌8 项研究
- 卵巢癌7 项研究
- 头颈鳞状细胞癌7 项研究
- 转移性癌症7 项研究
- 胰腺癌7 项研究
- 癌症（所有类型）7 项研究
- 黑色素瘤6 项研究
- 子宫内膜癌6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。